Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily A Burger

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
American Journal of Epidemiology|August 2, 2014
An updated natural history model of cervical cancer: derivation of model parametersNicole G Campos, Emily A Burger, Stephen Sy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 15, 2018
Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected MenEmily A Burger, Michael A Dyer, Stephen Sy, et al.
Lancet Regional Health. Americas|January 26, 2026
Single-dose HPV vaccination in the United States - a multi-modeling analysisEmily A Burger, Jean-François Laprise, Jennifer C Spencer, et al.
International Journal of Environmental Research and Public Health|October 14, 2022
Transition from Laser to Intravitreal Injections for Diabetic Retinopathy: Hospital Utilization and Costs from an Extended Healthcare PerspectiveSilvia Nanjala Walekhwa Hertzberg, Øystein K Jørstad, Beáta Éva Petrovski, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 2, 2018
An overview of cervical cancer epidemiology and prevention in ScandinaviaKine Pedersen, Sara Fogelberg, Lise H Thamsborg, et al.
Annals of Internal Medicine|September 29, 2015
Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness AnalysisJane J Kim, Nicole G Campos, Stephen Sy, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Population-level health impact of hypothetical waning 1-dose human papillomavirus vaccination and 2-dose mitigation strategies in a high cervical cancer burden settingEmily A Burger, Jean-François Laprise, Allison Portnoy, et al.
Preventive Medicine|October 15, 2018
Impact of human papillomavirus vaccination on the clinical meaning of cervical screening resultsPhilip E Castle, Xianhong Xie, Xiaonan Xue, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modelingMarc Brisson, Jean-François Laprise, Mélanie Drolet, et al.
European Clinical Respiratory Journal|May 22, 2026
Lung cancer screening in transition: highlights from the 3rd Oslo Lung Cancer Symposium, 2025Ghida Khalife, David Baldwin, Jussi Koivunen, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
American Journal of Epidemiology|August 2, 2014
An updated natural history model of cervical cancer: derivation of model parametersNicole G Campos, Emily A Burger, Stephen Sy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 15, 2018
Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected MenEmily A Burger, Michael A Dyer, Stephen Sy, et al.
Lancet Regional Health. Americas|January 26, 2026
Single-dose HPV vaccination in the United States - a multi-modeling analysisEmily A Burger, Jean-François Laprise, Jennifer C Spencer, et al.
International Journal of Environmental Research and Public Health|October 14, 2022
Transition from Laser to Intravitreal Injections for Diabetic Retinopathy: Hospital Utilization and Costs from an Extended Healthcare PerspectiveSilvia Nanjala Walekhwa Hertzberg, Øystein K Jørstad, Beáta Éva Petrovski, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 2, 2018
An overview of cervical cancer epidemiology and prevention in ScandinaviaKine Pedersen, Sara Fogelberg, Lise H Thamsborg, et al.
Annals of Internal Medicine|September 29, 2015
Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness AnalysisJane J Kim, Nicole G Campos, Stephen Sy, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Population-level health impact of hypothetical waning 1-dose human papillomavirus vaccination and 2-dose mitigation strategies in a high cervical cancer burden settingEmily A Burger, Jean-François Laprise, Allison Portnoy, et al.
Preventive Medicine|October 15, 2018
Impact of human papillomavirus vaccination on the clinical meaning of cervical screening resultsPhilip E Castle, Xianhong Xie, Xiaonan Xue, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modelingMarc Brisson, Jean-François Laprise, Mélanie Drolet, et al.
European Clinical Respiratory Journal|May 22, 2026
Lung cancer screening in transition: highlights from the 3rd Oslo Lung Cancer Symposium, 2025Ghida Khalife, David Baldwin, Jussi Koivunen, et al.
Pageof 7